Comments

Intellia Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Intellia Therapeutics (NTLA) operate in?

Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NTLANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q1 2025 Earnings were released on Thu May 8th, before the market open

The most recent conference call was at 8:00 AM, 7 days ago Click to view past webcast

Intellia Therapeutics (NTLA) Forecast

News Earnings Intellia Therapeutics (NTLA) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Intellia Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:NTLA | Benzinga

Explore Intellia Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NTLA.

Open	$7.85
Close	-
Volume / Avg.	615.43K / 3.65M
Day Range	$7.62 - $7.86
52 Wk Range	5.90 - 28.18
Market Cap	$804.84M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	31.59%
Days to Cover	9.6

Recent News

Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics, Offloads Meta Platforms

ARK Invest made significant trades in NTLA, META, VCYT, SYM, BIDU, and PATH. These moves come amidst changes in stock prices. Read more for full details.

Rounak Jain

Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$7.85
Close	-
Volume / Avg.	615.43K / 3.65M
Day Range	$7.62 - $7.86
52 Wk Range	5.90 - 28.18
Market Cap	$804.84M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	31.59%
Days to Cover	9.6

About Intellia Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based ther...

Got Questions? Ask

Analyze NTLA's financials

How has NTLA's EPS changed?

How is NTLA's EBITDA trending?

What is NTLA's debt-to-equity ratio?

What is NTLA's max drawdown this year?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Intellia Therapeutics (NTLA) stock?

You can purchase shares of Intellia Therapeutics (NASDAQ:NTLA) through any online brokerage.

View our list of the best stock brokerages

Who are Intellia Therapeutics (NTLA) competitors?

Other companies in Intellia Therapeutics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE) and Syndax Pharmaceuticals (NASDAQ:SNDX).

What is the forecast, or price target, for Intellia Therapeutics (NTLA) stock?

Intellia Therapeutics has a consensus price target of $48.08.

What is the current price for Intellia Therapeutics (NTLA)?

The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $7.77 last updated May 15, 2025 at 11:42 AM EDT.

Does Intellia Therapeutics (NTLA) pay a dividend?

There are no upcoming dividends for Intellia Therapeutics.

When is Intellia Therapeutics (NASDAQ:NTLA) reporting earnings?

Intellia Therapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Intellia Therapeutics (NTLA) going to split?

There is no upcoming split for Intellia Therapeutics.

What sector and industry does Intellia Therapeutics (NTLA) operate in?

Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.